Soaring Demand Set to Propel Genital Warts Market to $2.57 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Genital Warts Market Through 2025?
The market size of genital warts has seen a robust growth in the past few years. Its value is projected to expand from $1.97 billion in 2024 to $2.08 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.7%. The growth in this historical period has been driven by the emphasis on patient-centric care, prioritizing early detection and treatment, a rise in treatments aimed at self-target applications, as well as increased clinical trials and reoccurrence of genital warts.

What's the Projected Size of the Global Genital Warts Market by 2029?
The market for genital warts is set to witness significant expansion in the forthcoming years, with a valuation projected to reach $2.57 billion in 2029, growing at a Compound Annual Growth Rate (CAGR) of 5.4%. This growth during the estimated period is due to factors such as the implementation of digital health systems and telemedicine for remote healthcare consultation and progress tracking, the rise in demand for cost-effective and potent treatments for Sexually Transmitted Infections (STIs), increasing adoption of loop electrosurgical excision procedures, increasing demand for interferon alfa-n3 injection, and heightened accessibility of treatments. Key tendencies expected in this period are improvements in diagnostic technologies, a move towards combination treatments, growth of telehealth and virtual consultations, development of new therapeutic targets, and market penetration in emerging economies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Top Growth Drivers in the Genital Warts Industry: What's Accelerating the Market?
With the rise in sexually transmitted infections (STIs), the genital warts market is expected to see a significant uplift. STIs, which include infections spread primarily through sexual contact such as vaginal, anal, or , can be caused by bacteria, viruses, or parasites. The rampant increase in such infections is attributed to increased sexual activity, infrequent use of protection, and limited access to educational and healthcare services. Genital warts, a prevalent form of STI, are caused by certain strains of the human papillomavirus (HPV), and transmitted through direct skin-to-skin contact during sexual activity. As a case in point, October 2023 statistics from the Joint United Nations Programme on HIV/AIDS, a comprehensive Switzerland-based initiative aimed at preventing HIV infection, indicated that the number of people infected with HIV increased from approximately 38.7 million in 2021 to 39.0 million in 2022, with an additional 1.3 million new infections in 2022 alone. Consequently, the escalating prevalence of sexually transmitted infections (STIs) is contributing significantly to the growth of the genital warts market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

What Trends Will Shape the Genital Warts Market Through 2029 and Beyond?
Leading firms in the genital warts market are innovating new treatment methods, including the introduction of unique dermatology drugs, to counter the issues experienced by genital warts patients. These dermatology medications pertain to recently created pharmaceuticals or therapeutic items made specifically to address various dermatological issues, including genital warts. For example, Verrica Pharmaceuticals Inc., a US-based dermatology pharmaceutical organization, was granted New Chemical Entity (NCE) status for its drug candidate YCANTH in March 2023. YCANTH, which is in development to treat genital warts and has concluded phase 2 trials, gains a minimum of five years protection from generic competition with the FDA NCE status.

What Are the Main Segments in the Genital Warts Market?
The genital warts market covered in this report is segmented -

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid
2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments
3) By Gender: Female, Male
4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%
2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%
3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%
4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Which Top Companies are Driving Growth in the Genital Warts Market?
Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

Which Regions Will Dominate the Genital Warts Market Through 2029?
North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.